1. Home
  2. NMR vs ROIV Comparison

NMR vs ROIV Comparison

Compare NMR & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomura Holdings Inc ADR

NMR

Nomura Holdings Inc ADR

HOLD

Current Price

$8.13

Market Cap

22.8B

Sector

Finance

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$30.22

Market Cap

21.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMR
ROIV
Founded
1925
2014
Country
Japan
United Kingdom
Employees
27242
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.8B
21.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NMR
ROIV
Price
$8.13
$30.22
Analyst Decision
Buy
Strong Buy
Analyst Count
1
9
Target Price
N/A
$28.94
AVG Volume (30 Days)
1.3M
5.5M
Earning Date
04-24-2026
05-28-2026
Dividend Yield
4.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$8,260,000.00
Revenue This Year
$6.00
N/A
Revenue Next Year
$4.76
$744.61
P/E Ratio
$12.03
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.96
$10.71
52 Week High
$9.58
$32.79

Technical Indicators

Market Signals
Indicator
NMR
ROIV
Relative Strength Index (RSI) 51.90 56.00
Support Level $8.04 $26.65
Resistance Level $8.21 N/A
Average True Range (ATR) 0.14 1.12
MACD 0.03 0.20
Stochastic Oscillator 73.21 48.05

Price Performance

Historical Comparison
NMR
ROIV

About NMR Nomura Holdings Inc ADR

Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions world-wide, including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking, which is engaged in advisory, financing, and solutions businesses.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: